Three patients with homozygous familial hypercholesterolemia: Genomic sequencing and kindred analysis

被引:3
|
作者
Wong, Karen H. Y. [1 ]
Levy-Sakin, Michal [1 ]
Ma, Waifred [1 ]
Gonzaludo, Nina [1 ]
Mak, Angel C. Y. [1 ,2 ]
Vaka, Dedeem A. [3 ]
Poon, Annie [3 ]
Chu, Catherine [3 ]
Lao, Richard [3 ]
Balamir, Melek [4 ]
Grenville, Zoe [1 ]
Wong, Nicolas [1 ]
Kane, John P. [1 ,5 ,6 ]
Kwok, Pui-Yan [1 ,3 ,7 ]
Malloy, Mary J. [1 ,5 ,8 ]
Pullinger, Clive R. [1 ,9 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA
[4] Istanbul Univ, Dept Internal Med, Istanbul, Turkey
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[9] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 12期
基金
美国国家卫生研究院;
关键词
10xG linked-reads whole genome sequencing; dyslipidemia; LDL; whole exome sequencing; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL RECEPTOR GENE; MUTATIONS; IDENTIFICATION; POPULATION; PREVALENCE; VARIANTS; PLASMA; INDIVIDUALS; DISEASE;
D O I
10.1002/mgg3.1007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Homozygous Familial Hypercholesterolemia (HoFH) is an inherited recessive condition associated with extremely high levels of low-density lipoprotein (LDL) cholesterol in affected individuals. It is usually caused by homozygous or compound heterozygous functional mutations in the LDL receptor (LDLR). A number of mutations causing FH have been reported in literature and such genetic heterogeneity presents great challenges for disease diagnosis. Objective We aim to determine the likely genetic defects responsible for three cases of pediatric HoFH in two kindreds. Methods We applied whole exome sequencing (WES) on the two probands to determine the likely functional variants among candidate FH genes. We additionally applied 10x Genomics (10xG) Linked-Reads whole genome sequencing (WGS) on one of the kindreds to identify potentially deleterious structural variants (SVs) underlying HoFH. A PCR-based screening assay was also established to detect the LDLR structural variant in a cohort of 641 patients with elevated LDL. Results In the Caucasian kindred, the FH homozygosity can be attributed to two compound heterozygous LDLR damaging variants, an exon 12 p.G592E missense mutation and a novel 3kb exon 1 deletion. By analyzing the 10xG phased data, we ascertained that this deletion allele was most likely to have originated from a Russian ancestor. In the Mexican kindred, the strikingly elevated LDL cholesterol level can be attributed to a homozygous frameshift LDLR variant p.E113fs. Conclusions While the application of WES can provide a cost-effective way of identifying the genetic causes of FH, it often lacks sensitivity for detecting structural variants. Our finding of the LDLR exon 1 deletion highlights the broader utility of Linked-Read WGS in detecting SVs in the clinical setting, especially when HoFH patients remain undiagnosed after WES.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Targeted exome sequencing in South Indian patients with Familial hypercholesterolemia
    Ashavaid, Tester F.
    Vishwanathan, Sunitha
    Pillai, Krishna Kumar B.
    Shah, Swarup A., V
    Reddy, Lakshmi Lavanya
    CLINICA CHIMICA ACTA, 2022, 527 : 47 - 55
  • [2] Homozygous Familial Hypercholesterolemia
    Nohara, Atsushi
    Tada, Hayato
    Ogura, Masatsune
    Okazaki, Sachiko
    Ono, Koh
    Shimano, Hitoshi
    Daida, Hiroyuki
    Dobashi, Kazushige
    Hayashi, Toshio
    Hori, Mika
    Matsuki, Kota
    Minamino, Tetsuo
    Yokoyama, Shinji
    Harada-Shiba, Mariko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (07) : 665 - 678
  • [3] Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
    Khera, Amit V.
    Won, Hong-Hee
    Peloso, Gina M.
    Lawson, Kim S.
    Bartz, Traci M.
    Deng, Xuan
    van Leeuwen, Elisabeth M.
    Natarajan, Pradeep
    Emdin, Connor A.
    Bick, Alexander G.
    Morrison, Alanna C.
    Brody, Jennifer A.
    Gupta, Namrata
    Nomura, Akihiro
    Kessler, Thorsten
    Duga, Stefano
    Bis, Joshua C.
    van Duijn, Cornelia M.
    Cupples, L. Adrienne
    Psaty, Bruce
    Rader, Daniel J.
    Danesh, John
    Schunkert, Heribert
    McPherson, Ruth
    Farrall, Martin
    Watkins, Hugh
    Lander, Eric
    Wilson, James G.
    Correa, Adolfo
    Boerwinkle, Eric
    Merlini, Piera Angelica
    Ardissino, Diego
    Saleheen, Danish
    Gabriel, Stacey
    Kathiresan, Sekar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (22) : 2578 - 2589
  • [4] Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia
    Wiegman, Albert
    Greber-Platzer, Susanne
    Ali, Shazia
    Reijman, M. Doortje
    Brinton, Eliot A.
    Charng, Min-Ji
    Srinivasan, Shubha
    Baker-Smith, Carissa
    Baum, Seth
    Brothers, Julie A.
    Hartz, Jacob
    Moriarty, Patrick M.
    Mendell, Jeanne
    Bihorel, Sebastien
    Banerjee, Poulabi
    George, Richard T.
    Hirshberg, Boaz
    Pordy, Robert
    CIRCULATION, 2024, 149 (05) : 343 - 353
  • [5] Evolocumab in patients with homozygous familial hypercholesterolemia in India
    Bansal, Sandeep
    Ruzza, Andrea
    Sawhney, Jps
    Kulkarni, Govind
    Iyengar, Shammana
    Mehta, Vimal
    Hamer, Andrew
    Wu, You
    Raal, Frederick J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (06) : 814 - 821
  • [6] Next-generation sequencing to confirm clinical familial hypercholesterolemia
    Reeskamp, Laurens F.
    Tromp, Tycho R.
    Defesche, Joep C.
    Grefhorst, Aldo
    Stroes, Erik S. G.
    Hovingh, G. Kees
    Zuurbier, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) : 875 - 883
  • [7] Next-generation sequencing to confirm clinical familial hypercholesterolemia
    Reeskamp, Laurens F.
    Tromp, Tycho R.
    Defesche, Joep C.
    Grefhorst, Aldo
    Stroes, Erik S. G.
    Hovingh, G. Kees
    Zuurbier, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020,
  • [8] Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia
    Lamiquiz-Moneo, Itziar
    Civeira, Fernando
    Mateo-Gallego, Rocio
    Laclaustra, Martin
    Moreno-Franco, Belen
    Teresa Tejedor, Maria
    Palacios, Lourdes
    Martin, Cesar
    Cenarro, Ana
    REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (08): : 664 - 673
  • [9] A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia
    Di Taranto, Maria Donata
    Giacobbe, Carola
    Buonaiuto, Alessio
    Calcaterra, Ilenia
    Palma, Daniela
    Maione, Giovanna
    Iannuzzo, Gabriella
    Di Minno, Matteo Nicola Dario
    Rubba, Paolo
    Fortunato, Giuliana
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [10] Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemia
    Khoury, Etienne
    Croteau, Laurent
    Lauziere, Alex
    Gaudet, Daniel
    FUTURE CARDIOLOGY, 2022, 18 (06) : 507 - 518